<qa>  What is the effect of omalizumab on markers of impairment in patients withThis study will evaluate the effect of omalizumab on markers of impairment in patients with inadequately controlled persistent allergic asthma on Step 4 or above therapy as defined in the 2007 National Heart, Lung, and Blood Institute NHBLI Guidelines 